Absorbent dressings at the outpatient stage of treatment of tissue defects in patients with diabetic foot syndrome
https://doi.org/10.21518/akh2025-029
Abstract
Introduction. Diabetic foot syndrome (DFS) occurs in 25% of DM patients and is an indication for performing 40–60% of lower limb amputations of a non-traumatic nature. The problem of effective local action on purulent infection in diabetes mellitus remains unresolved to this day.
Aim. To study the local effect of modern sorbent dressings on the course of the wound process in diabetic foot syndrome.
Materials and methods. A rhabdomized prospective study was conducted to study the effectiveness of superabsorbent bandages with a silicone contact layer (Zetuvit Plus Silicone) in the topical treatment of SDS in 296 patients. The main group included 154 patients, average age 54.7 ± 12.63 years, of which 74 were men and 80 were women. The comparison group included 142 patients, average age 52.5 ± 13.67 years, of which 70 were men and 72 were women.
Results. Ulceration and the appearance of granulations when applying Zetuvit Plus Silicone dressings occurred after 14.4 ± 0.7 days, the appearance of marginal epithelialization and complete wound healing occurred on 17.2 ± 2.6 and 21.0 ± 3.6 days, respectively.
Discussion. The introduction of sorbent dressings into clinical practice has brought significant benefits to patients with SDS, minimizing the risk of injury and pain associated with the use of adhesive and adhesive bandages. The spread of this technique of local treatment of trophic ulcers in DM ensures satisfaction with the treatment results of patients and doctors.
Conclusions. Zetuvit Plus Silicone superabsorbent dressings act at all stages of the wound process and improve the tissue regeneration process.
About the Authors
K. A. Koreyba
Kazan State Medical University
Russian Federation
Russian Federation
Konstantin A. Koreyba, Cand. Sci. (Med.), Honored Doctor of the Republic of Tatarstan, Associate Professor of the Department of Surgical Diseases,
49, Butlerov St., Kazan, 420012
P. S. Lukin
Perm State Medical University named after E.A. Wagner
Russian Federation
Russian Federation
Pavel S. Lukin, Cand. Sci. (Med.), Associate Professor of the Department of Faculty Surgery No. 2,
26, Petropavlovskaya St., Perm, 614990
E. P. Krivoshchekov
Samara State Medical University
Russian Federation
Russian Federation
Evgeny P. Krivoshchekov, Dr. Sci. (Med.), Professor, Professor of the Department of Surgery of the Institute of Postgraduate Education,
89, Chapaevskaya St., Samara, 443099
References
1. Заривчацкий МФ. Синдром диабетической стопы. Пермь: ФГБОУ ВО ПГМУ им. академика Е.А. Вагнера Минздрава России; 2020. 98 с.
2. Perez-Favila A, Martinez-Fierro ML, Rodriguez-Lazalde JG, Cid-Baez MA, Zamudio-Osuna MDJ, Martinez-Blanco MDR et al. Current therapeutic strategies in diabetic foot ulcers. Medicina. 2019;55(11):1–21. https://doi.org/10.3390/medicina55110714.
3. Silverstein P, Heimbach D, Meites H, Latenser B, Mozingo D, Mullins F et al. An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-con-taining soft silicone foam dressing (intervention) vs silver sulfadia-zine cream. J Burn Care Res. 2011;32(6):617–626. https://doi.org/10.1097/BCR.0b013e318236fe31.
4. Krivoshchekov EP, Elshin EB, Alyapyshev GS, Poseryaev AV. The use of histoequivalent-bioplastic material for chronic foot ulcers on patients with diabetes. Bulletin of the Medical Institute “REAVIZ”: Rehabilitation, Doctor, and Health. 2021;(6):61–70. (In Russ.) https://doi.org/10.20340/vmi-rvz.2021.6.CLIN.2.
5. Krivoshchekov EP. Experience of using chitosan and carboxymethylcellulose in the early postoperative period in patients with diabetic foot syndrome complications. Al’manakh Instituta Khirurgii im. A.V. Vishnevskogo 2020;(2):845–846. (In Russ.)
6. Lichman LL, Katorkin SE, Andreev PS. Evaluation of the effectiveness of the use of modern self-adhesive silicone postoperative dressings. Ambulatornaya Khirurgiya. 2023;20(2):96–100. (In Russ.) https://doi.org/10.21518/akh2023-028.
7. Бенсман ВМ (ред.). Хирургия гнойно-некротических осложнений диабетической стопы. М.: Медпрактика; 2015. 495 c.
8. Заривчацкий МФ (ред.). Особенности диагностики и лечения хирургических заболеваний на фоне сахарного диабета. Пермь; 2021. 128 с.
9. Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev Ctries. 2010;30:75–79. https://doi.org/10.4103/0973-3930.62596.
10. Tickle J. Introducing a new superabsorbent dressing to manage wound exudate. Br J Nurs. 2017;26(Suppl. 20):S38-S45. https://doi.org/10.12968/bjon.2017.26.Sup20.S38.
11. Ступин ВА (ред.). Синдром диабетической стопы. Эпидемиология, патофизиология, диагностика и лечение. М.: Литтерра; 2019. 200 с.
12. Tong JW. Case reports on the use of antimicrobial (silver impregnated) soft silicone foam dressing on infected diabetic foot ulcers. Int Wound J. 2009;6(4):275–284. https://doi.org/10.1111/j.1742-481X.2009.00610.x.
13. Amin N, Doupis J. Diabetic foot disease: From the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153. https://doi.org/10.4239/wjd.v7.i7.153.
14. Murashkin NN, Epishev RV, Materikin AI, Ambarchian ET, Opryatin LA, Ivanov RA. Current Dressings in Skin Diseases Management. Current Pediatrics. 2020;19(6):420–431. (In Russ.) https://doi.org/10.15690/vsp.v19i6.2143.
15. Faucher N, Safar H, Baret M, Philippe A, Farid R. Superabsorbent dressings for copiously exuding wounds. Br J Nurs. 2012;21(12):S22–S28. https://doi.org/10.12968/bjon.2012.21.Sup12.S22.
16. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010;(3):CD006478. https://doi.org/10.1002/14651858.CD006478.pub2.
17. Wiegand C, Hipler UC, Elsner P, Tittelbach J. Clinical efficacy of dressings for treatment of heavily exuding chronic wounds. Chronic Wound Care Manag Res. 2015;2015(2):101–111. https://doi.org/10.2147/CWCMR.S60315.
18. Shi J, Barakat M, Chen D, Chen L. Bicellular tight junctions and wound healing. Int J Mol Sci. 2018;19(12):3862. https://doi.org/10.3390/ ijms19123862.
19. Atkin L, Barrett S, Chadwick P, Callaghan R, Rippon MG, Rogers AA, Simm S. Evaluation of a superabsorbent wound dressing, patient and clinician perspective: a case series. J Wound Care. 2020;29(3):174–182. https://doi.org/10.12968/jowc.2020.29.3.174.
20. Blackburn J, Stephenson J, Ousey K, Atkin L. Exploring and understanding challenges in clinical practice: appropriate dressing wear time. Wounds UK. 2018;14(5):56–64. Available at: https://wounds-uk.com/journal-articles/exploring-and-understanding-challengesinclinical-practice-appropriate-dressing-wear-time.
21. Holloway S. Skin considerations for older adults with wounds. Br J Community Nurs. 2019;24(Suppl. 6):S15-S19. https://doi.org/10.12968/bjcn.2019.24.Sup6.S15.
Review
For citations:
Koreyba K.A., Lukin P.S., Krivoshchekov E.P. Absorbent dressings at the outpatient stage of treatment of tissue defects in patients with diabetic foot syndrome. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2025;22(1):140-145. (In Russ.) https://doi.org/10.21518/akh2025-029
Views:
533
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 